Risk of persistent or recurrent cervical neoplasia in patients with ‘pure’ adenocarcinoma‐in‐situ (<scp>AIS</scp>) or mixed <scp>AIS</scp> and high‐grade cervical squamous neoplasia (cervical intra‐epithelial neoplasia grades 2 and 3 (<scp>CIN</scp> 2/3)): a population‐based study
E Codde(The University of Notre Dame Australia), Paul A. Cohen(The University of Western Australia), Aime Munro(St John of God Subiaco Hospital), Jim Codde(The University of Notre Dame Australia), Yuet‐Kin Leung(Winthrop Rockefeller Foundation), Scott E. Bowen, Katrina Spilsbury(Curtin University), J Tan(St John of God Subiaco Hospital), Nerida Steel(Pancreatic Cancer Action Network), CJR Stewart(The University of Western Australia), G. Raj K. A. Mohan(St John of God Subiaco Hospital), SG Salfinger(St John of God Subiaco Hospital)
Cited by 13
Related Papers
The quanitification of drug caused morbidity and mortality in Australia: Part 1
|UWA Profiles and Research Repository (University of Western Australia)|1995|470
Poor Long-Term Survival in Patients With Moderate Aortic Stenosis
|Journal of the American College of Cardiology|2019|418
Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes
|ILAR Journal|2012|301
Dynamic Regulation of Estrogen Receptor-β Expression by DNA Methylation During Prostate Cancer Development and Metastasis
|American Journal Of Pathology|2004|202
Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth.
|Molecular Endocrinology|1993|160